A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Novartis Ag stock. As of the latest transaction made, Gotham Asset Management, LLC holds 1,956 shares of NVS stock, worth $257,311. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,956
Previous 1,765 10.82%
Holding current value
$257,311
Previous $213,000 17.37%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$113.5 - $129.73 $21,678 - $24,778
191 Added 10.82%
1,956 $250,000
Q2 2025

Aug 14, 2025

BUY
$101.96 - $121.01 $179,959 - $213,582
1,765 New
1,765 $213,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.